Healthcare -
Biotechnology - NASDAQ - US
$ 21.7
2.12 %
$ 238 M
Market Cap
-0.91
P/E
CDTX - COST OF REVENUE
Cost of Revenue CDTX - Cidara Therapeutics, Inc.
1.52 M
LAST VALUE
183.87%
2 YEAR CAGR
23.83%
5 YEAR CAGR
0.00%
10 YEAR CAGR